Antigen-Presenting Cell Activation for Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for directing stem/progenitor cell activation and differentiation, particularly using antigen-presenting cells and dendritic cells, face limitations in efficiently inducing specific cellular responses for therapeutic applications such as tissue regeneration, cancer immunity, and autoimmunity disorders, with a need for more effective methods to enhance cell engraftment and homeostasis.
Innovation Solution
The method involves obtaining and enriching populations of immature antigen-presenting cells and stem/progenitor cells, activating the antigen-presenting cells, and co-culturing them with tissue-derived cells to induce differentiation, expansion, activation, and secretion of specific molecules, generating lineage-specific precursor/progenitor populations that can be used for therapeutic and diagnostic purposes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antigen-presenting cells and dendritic cells are used to direct stem/progenitor cell activation and differentiation, then specific cellular responses are induced, but the efficiency and effectiveness of therapeutic applications are limited
Solution Approach 1:
The patent modifies the functional state of antigen-presenting cells by controlling their maturation level and activation status. By adjusting these parameters, the system optimizes both the efficiency of stem cell activation and the reliability of therapeutic responses. The method uses specific culture conditions and timing to achieve the desired cellular responses for tissue regeneration and cancer immunity treatments.
2Reliability
If stem cells are used for tissue regeneration, then tissue repair capabilities are enhanced, but cell engraftment efficiency needs improvement
Solution Approach 1:
The patent applies preliminary action by pre-activating antigen-presenting cells and preparing them in specific maturation states before introducing stem cells. This preparatory step creates an optimized microenvironment that enhances subsequent stem cell engraftment efficiency while maintaining tissue regeneration capabilities. The method includes pre-culturing APCs under controlled conditions to ensure they are ready to effectively support stem cell integration.
Data Source
AI summary
A method is provided, including obtaining a population of isolated immature antigen-presenting cells; enriching a population of isolated stem/progenitor cells within a larger population of cells; activating the population of immature antigen-presenting cells; and following the activating, inducing at least one process selected from the group consisting of: differentiation, expansion, activation, secretion of a molecule, and expression of a marker, by exposing the enriched stem/progenitor cell population to the population of activated antigen-presenting cells. Inducing the at least one process includes generating a lineage specific precursor/progenitor population (LSP) from the enriched stem/progenitor cell population. In addition, (1) obtaining the population of immature antigen-presenting cells includes obtaining the population of immature antigen-presenting cells from umbilical cord blood, and/or (2) enriching the population of stem/progenitor cells includes obtaining the population of stem/progenitor cells from umbilical cord blood. Other applications are also described.